Epidemiology of childhood leukemia in the presence and absence of Down syndrome

Cancer Epidemiology

Volumn 38, Issue 5, 2014, Pages 479-489

  Mezei, Gabor ^a   Sudan, Madhuri ^b   Izraeli, Shai ^c,d   Kheifets, Leeka ^b  

^a EXPONENT INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHEBA MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute leukemia; Childhood leukemia; Children; Down syndrome; Etiology

Indexed keywords

PESTICIDE;

ACUTE MYELOBLASTIC LEUKEMIA; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; DOWN SYNDROME; ENVIRONMENTAL EXPOSURE; HUMAN; LEUKEMOGENESIS; POPULATION; REVIEW; RISK FACTOR; ADVERSE EFFECTS; CHILD; GENETICS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; PATHOLOGY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

CHILD; DOWN SYNDROME; ENVIRONMENTAL EXPOSURE; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 84908093352     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.07.006     Document Type: Review

References (177)

1. Pui C.-H. Childhood leukemias 2006, Cambridge University Press, Cambridge. 2nd ed.
2. Howlader N., Noone A., Krapcho M., Neyman N., Aminou R., Waldron W., et al. SEER cancer statistics review, 1975-2009 (vintage 2009 populations) 2012, National Cancer Institute, Bethesda, MD.
3. Kaatsch P., Steliarova-Foucher E., Crocetti E., Magnani C., Spix C., Zambon P. Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006, 42:1961-1971.
4. World Health Organization. Environmental health criteria 238: extremely low frequency fields. Geneva, Switzerland; 2007.
5. Infante-Rivard C. Chemical risk factors and childhood leukaemia: a review of recent studies. Radiat Prot Dosimetry 2008, 132:220-227.
6. Mezei G., Kheifets L. Selection bias and its implications for case-control studies: a case study of magnetic field exposure and childhood leukaemia. Int J Epidemiol 2006, 35:397-406.
7. Kheifets L., Oksuzyan S. Exposure assessment and other challenges in non-ionizing radiation studies of childhood leukaemia. Radiat Prot Dosimetry 2008, 132:139-147.
8. Sudan M., Mezei G., Kheifets L. Novel epidemiologic approaches to investigate the magnetic field - childhood leukemia association. Childhood Cancer 2012 2012, Children with Cancer UK, London, England.
9. Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Brit J Haematol 2000, 110:512-524.
10. Sherman S.L., Allen E.G., Bean L.H., Freeman S.B. Epidemiology of Down syndrome. Mental Retard Dev Disabil Res Rev 2007, 13:221-227.
11. Gardiner K., Herault Y., Lott I.T., Antonarakis S.E., Reeves R.H., Dierssen M. Down syndrome: from understanding the neurobiology to therapy. J Neurosci: Off J Soc Neurosci 2010, 30:14943-14945.
12. Baccichetti C., Lenzini E., Pegoraro R. Down syndrome in the Belluno district (Veneto region, northeast Italy): age distribution and morbidity. Am J Med Genet Suppl 1990, 7:84-86.
13. Raut P., Sriram B., Yeoh A., Hee K.Y., Lim S.B., Daniel M.L. High prevalence of hearing loss in Down syndrome at first year of life. Ann Acad Med Singap 2011, 40:493-498.
14. Goldacre M.J., Wotton C.J., Seagroatt V., Yeates D. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child 2004, 89:1014-1017.
15. Zhu J.L., Hasle H., Correa A., Schendel D., Friedman J.M., Olsen J., et al. Survival among people with Down syndrome: a nationwide population-based study in Denmark. Genet Med 2013, 15:64-69.
16. Zhu J.L., Hasle H., Correa A., Schendel D., Friedman J.M., Olsen J., et al. Hospitalizations among people with Down syndrome: a nationwide population-based study in Denmark. Am J Med Genet A 2013, 161:650-657.
17. Centers for Disease Control and Prevention Improved national prevalence estimates for 18 selected major birth defects - United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2006, 54:1301-1305.
18. Centers for Disease Control and Prevention Down syndrome prevalence at birth - United States, 1983-1990. MMWR Morb Mortal Wkly Rep 1994, 43:617-622.
19. Parker S.E., Mai C.T., Canfield M.A., Rickard R., Wang Y., Meyer R.E., et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A: Clin Mol Teratol 2010, 88:1008-1016.
20. Melve K.K., Lie R.T., Skjaerven R., Van Der Hagen C.B., Gradek G.A., Jonsrud C., et al. Registration of Down syndrome in the Medical Birth Registry of Norway: validity and time trends. Acta Obstet Gynecol Scand 2008, 87:824-830.
21. Metneki J., Czeizel A.E. Increasing total prevalence rate of cases with Down syndrome in Hungary. Eur J Epidemiol 2005, 20:525-535.
22. Takeuchi A., Ehara H., Ohtani K., Maegaki Y., Nanba Y., Nagata I., et al. Live birth prevalence of Down syndrome in Tottori, Japan, 1980-1999. Am J Med Genet A 2008, 146A:1381-1386.
23. Cocchi G., Gualdi S., Bower C., Halliday J., Jonsson B., Myrelid Å., et al. International trends of Down syndrome 1993-2004: births in relation to maternal age and terminations of pregnancies. Birth Defects Res A: Clin Mol Teratol 2010, 88:474-479.
24. Dolk H., Loane M., Garne E., De Walle H., Queisser-Luft A., De Vigan C., et al. Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980-1999. Rev Epidemiol Sante Publique 2005, 53(Spec No. 2):S87-S95.
25. Morris J.K., Mutton D.E., Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 2002, 9:2-6.
26. Irving C., Basu A., Richmond S., Burn J., Wren C. Twenty-year trends in prevalence and survival of Down syndrome. Eur J Hum Genet: EJHG 2008, 16:1336-1340.
27. Canfield M.A., Honein M.A., Yuskiv N., Xing J., Mai C.T., Collins J.S., et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A: Clin Mol Teratol 2006, 76:747-756.
28. Khoshnood B., De Vigan C., Vodovar V., Bréart G., Goffinet F., Blondel B. Advances in medical technology and creation of disparities: the case of Down syndrome. Am J Public Health 2006, 96:2139-2144.
29. Wahab A.A., Bener A., Sandridge A.L., Hoffmann G.F. The pattern of Down syndrome among children in Qatar: a population-based study. Birth Defects Res A: Clin Mol Teratol 2006, 76:609-612.
30. Rosner G., Rosner S., Orr-Urtreger A. Genetic testing in Israel: an overview. Ann Rev Genom Hum Genet 2009, 10:175-192.
31. Cheng Y., Wang H., Wang H., Chen Z., Jin J. Trisomy 21 in patients with acute leukemia. Am J Hematol 2009, 84:193-194.
32. James R., Lightfoot T., Simpson J., Moorman A.V., Roman E., Kinsey S., et al. Acute leukemia in children with Down's syndrome: the importance of population based study. Haematologica 2008, 93:1262-1263.
33. Zeller B., Gustafsson G., Forestier E., Abrahamsson J., Clausen N., Heldrup J., et al. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br J Haematol 2005, 128:797-804.
34. Hasle H., Clemmensen I.H., Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000, 355:165-169.
35. Patja K., Pukkala E., Sund R., Iivanainen M., Kaski M. Cancer incidence of persons with Down syndrome in Finland: a population-based study. Int J Cancer 2006, 118:1769-1772.
36. Roy A., Cowan G., Mead A.J., Filippi S., Bohn G., Chaidos A., et al. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A 2012, 109:17579-17584.
37. Tunstall-Pedoe O., Roy A., Karadimitris A., de la Fuente J., Fisk N.M., Bennett P., et al. Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood 2008, 112:4507-4511.
38. Chou S.T., Opalinska J.B., Yao Y., Fernandes M.A., Kalota A., Brooks J.S., et al. Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood 2008, 112:4503-4506.
39. Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol 2001, 2:429-436.
40. Bjorge T., Cnattingius S., Lie R.T., Tretli S., Engeland A. Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev 2008, 17:500-506.
41. Malinge S., Izraeli S., Crispino J.D. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood 2009, 113:2619-2628.
42. Birger Y., Goldberg L., Chlon T.M., Goldenson B., Muler I., Schiby G., et al. Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder. Blood 2013, 122:988-998.
43. Roberts I., Alford K., Hall G., Juban G., Richmond H., Norton A., et al. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood 2013, 122(24):3908-3917.
44. Yoshida K., Toki T., Okuno Y., Kanezaki R., Shiraishi Y., Sato-Otsubo A., et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet 2013, 45:1293-1299.
45. Ford A.M., Bennett C.A., Price C.M., Bruin M.C., Van Wering E.R., Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci U S A 1998, 95:4584-4588.
46. Greaves M. Pre-natal origins of childhood leukemia. Rev Clin Exp Hematol 2003, 7:233-245.
47. Greaves M.F., Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003, 3:639-649.
48. Gruhn B., Taub J.W., Ge Y., Beck J.F., Zell R., Hafer R., et al. Prenatal origin of childhood acute lymphoblastic leukemia, association with birth weight and hyperdiploidy. Leukemia 2008, 22:1692-1697.
49. Hong D., Gupta R., Ancliff P., Atzberger A., Brown J., Soneji S., et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 2008, 319:336-339.
50. Taub J.W., Konrad M.A., Ge Y., Naber J.M., Scott J.S., Matherly L.H., et al. High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood 2002, 99:2992-2996.
51. Wiemels J.L., Cazzaniga G., Daniotti M., Eden O.B., Addison G.M., Masera G., et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 1999, 354:1499-1503.
52. Boker L.K., Blumstein T., Sadetzki S., Luxenburg O., Litvak I., Akstein E., et al. Incidence of leukemia and other cancers in Down syndrome subjects in Israel. Int J Cancer 2001, 93:741-744.
53. Buitenkamp T.D., Izraeli S., Zimmermann M., Forestier E., Heerema N.A., van den Heuvel-Eibrink M.M., et al. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood 2014, 123(1):70-77.
54. Forestier E., Izraeli S., Beverloo B., Haas O., Pession A., Michalova K., et al. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Blood 2008, 111:1575-1583.
55. Bercovich D., Ganmore I., Scott L.M., Wainreb G., Birger Y., Elimelech A., et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet 2008, 372:1484-1492.
56. Hertzberg L., Vendramini E., Ganmore I., Cazzaniga G., Schmitz M., Chalker J., et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood 2010, 115:1006-1017.
57. Mullighan C.G., Collins-Underwood J.R., Phillips L.A., Loudin M.G., Liu W., Zhang J., et al. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet 2009, 41:1243-1246.
58. Russell L.J., Capasso M., Vater I., Akasaka T., Bernard O.A., Calasanz M.J., et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood 2009, 114:2688-2698.
59. Shochat C., Tal N., Bandapalli O.R., Palmi C., Ganmore I., te Kronnie G., et al. Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med 2011, 208:901-908.
60. Cario G., Zimmermann M., Romey R., Gesk S., Vater I., Harbott J., et al. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Blood 2010, 115:5393-5397.
61. Ensor H.M., Schwab C., Russell L.J., Richards S.M., Morrison H., Masic D., et al. Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. Blood 2011, 117:2129-2136.
62. Harvey R.C., Mullighan C.G., Chen I.M., Wharton W., Mikhail F.M., Carroll A.J., et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 2010, 115:5312-5321.
63. Palmi C., Vendramini E., Silvestri D., Longinotti G., Frison D., Cario G., et al. Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia. Leukemia 2012, 26:2245-2253.
64. Whitlock J.A. Down syndrome and acute lymphoblastic leukaemia. Br J Haematol 2006, 135:595-602.
65. Whitlock J.A., Sather H.N., Gaynon P., Robison L.L., Wells R.J., Trigg M., et al. Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 2005, 106:4043-4049.
66. Maloney K.W., Carroll W.L., Carroll A.J., Devidas M., Borowitz M.J., Martin P.L., et al. Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group. Blood 2010, 116:1045-1050.
67. Blair C.K., Roesler M., Xie Y., Gamis A.S., Olshan A.F., Heerema N.A., et al. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study. Paediatric Perinat Epidemiol 2008, 22:288-295.
68. Puumala S.E., Ross J.A., Olshan A.F., Robison L.L., Smith F.O., Spector L.G. Reproductive history, infertility treatment, and the risk of acute leukemia in children with Down syndrome: a report from the Children's Oncology Group. Cancer 2007, 110:2067-2074.
69. Linabery A.M., Olshan A.F., Gamis A.S., Smith F.O., Heerema N.A., Blair C.K., et al. Exposure to medical test irradiation and acute leukemia among children with Down syndrome: a report from the Children's Oncology Group. Pediatrics 2006, 118:e1499-e1508.
70. Ognjanovic S., Puumala S., Spector L.G., Smith F.O., Robison L.L., Olshan A.F., et al. Maternal health conditions during pregnancy and acute leukemia in children with Down syndrome: a Children's Oncology Group study. Pediatric Blood Cancer 2009, 52:602-608.
71. Ross J.A., Blair C.K., Olshan A.F., Robison L.L., Smith F.O., Heerema N.A., et al. Periconceptional vitamin use and leukemia risk in children with Down syndrome: a Children's Oncology Group study. Cancer 2005, 104:405-410.
72. Alderton L.E., Spector L.G., Blair C.K., Roesler M., Olshan A.F., Robison L.L., et al. Child and maternal household chemical exposure and the risk of acute leukemia in children with Down's syndrome: a report from the Children's Oncology Group. Am J Epidemiol 2006, 164:212-221.
73. Canfield K.N., Spector L.G., Robison L.L., Lazovich D., Roesler M., Olshan A.F., et al. Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group. Br J Cancer 2004, 91:1866-1872.
74. Linabery A.M., Blair C.K., Gamis A.S., Olshan A.F., Heerema N.A., Ross J.A. Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study. Cancer Epidemiol Biomarkers Prev 2008, 17:2572-2577.
75. Mejia-Arangure J.M., Fajardo-Gutierrez A., Flores-Aguilar H., Martinez-Garcia M.C., Salamanca-Gomez F., Palma-Padilla V., et al. Environmental factors contributing to the development of childhood leukemia in children with Down's syndrome. Leukemia: Off J Leukemia Soc Am Leukemia Res Fund UK 2003, 17:1905-1907.
76. Mejia-Arangure J.M., Fajardo-Gutierrez A., Perez-Saldivar M.L., Gorodezky C., Martinez-Avalos A., Romero-Guzman L., et al. Magnetic fields and acute leukemia in children with Down syndrome. Epidemiology 2007, 18:158-161.
77. Flores-Lujano J., Perez-Saldivar M.L., Fuentes-Panana E.M., Gorodezky C., Bernaldez-Rios R., Del Campo-Martinez M.A., et al. Breastfeeding and early infection in the aetiology of childhood leukaemia in Down syndrome. Br J Cancer 2009, 101:860-864.
78. Nunez-Enriquez J.C., Fajardo-Gutierrez A., Buchan-Duran E.P., Bernaldez-Rios R., Medina-Sanson A., Jimenez-Hernandez E., et al. Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia. Br J Cancer 2013, 108:2334-2338.
79. Shu X.O., Han D., Severson R.K., Chen Z., Neglia J.P., Reaman G.H., et al. Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 2002, 13:15-25.
80. van Steensel-Moll H.A., Valkenburg H.A., Vandenbroucke J.P., van Zanen G.E. Are maternal fertility problems related to childhood leukaemia. Int J Epidemiol 1985, 14:555-559.
81. Dorak M.T., Pearce M.S., Hammal D.M., McNally R.J., Parker L. Examination of gender effect in birth weight and miscarriage associations with childhood cancer (United Kingdom). Cancer Causes Control 2007, 18:219-228.
82. Ma X., Metayer C., Does M., Buffler P. Maternal pregnancy loss, birth characteristics, and childhood leukemia (United States). Cancer Causes Control 2005, 16:1075-1083.
83. Schuz J., Kaatsch P., Kaletsch U., Meinert R., Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 1999, 28:631-639.
84. Petridou E.T., Sergentanis T.N., Panagopoulou P., Moschovi M., Polychronopoulou S., Baka M., et al. In vitro fertilization and risk of childhood leukemia in Greece and Sweden. Pediatric Blood Cancer 2012, 58:930-936.
85. Rudant J., Amigou A., Orsi L., Althaus T., Leverger G., Baruchel A., et al. Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: The ESCALE study (SFCE). Pediatric Blood Cancer 2013, 60(2):301-308.
86. Johnson K.J., Soler J.T., Puumala S.E., Ross J.A., Spector L.G. Parental and infant characteristics and childhood leukemia in Minnesota. BMC Pediatrics 2008, 8:7.
87. Neglia J.P., Linet M.S., Shu X.O., Severson R.K., Potter J.D., Mertens A.C., et al. Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2000, 82:234-240.
88. McKinney P.A., Juszczak E., Findlay E., Smith K., Thomson C.S. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer 1999, 80:1844-1851.
89. Murray L., McCarron P., Bailie K., Middleton R., Davey Smith G., Dempsey S., et al. Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study. Br J Cancer 2002, 86:356-361.
90. Roman E., Simpson J., Ansell P., Lightfoot T., Mitchell C., Eden T.O.B. Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. Eur J Cancer 2005, 41:749-759.
91. Milne E., Laurvick C.L., Blair E., Bower C., de Klerk N. Fetal growth and acute childhood leukemia: looking beyond birth weight. Am J Epidemiol 2007, 166:151-159.
92. Oksuzyan S., Crespi C.M., Cockburn M., Mezei G., Kheifets L. Birth weight and other perinatal characteristics and childhood leukemia in California. Cancer Epidemiol 2012, 36:e359-e365.
93. Westergaard T., Andersen P.K., Pedersen J.B., Olsen J.H., Frisch M., Sorensen H.T., et al. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 1997, 89:939-947.
94. Dockerty J.D., Draper G., Vincent T., Rowan S.D., Bunch K.J. Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol 2001, 30:1428-1437.
95. Reynolds P., Behren J.V., Elkin E.P. Birth characteristics and leukemia in young children. Am J Epidemiol 2002, 155:603-613.
96. Larfors G., Hallbook H., Simonsson B. Parental age, family size, and offspring's risk of childhood and adult acute leukemia. Cancer Epidemiol Biomarkers Prev 2012, 21:1185-1190.
97. Milne E., Greenop K.R., Metayer C., Schuz J., Petridou E., Pombo-de-Oliveira M.S., et al. Fetal growth and childhood acute lymphoblastic leukemia: findings from the childhood leukemia international consortium. Int J Cancer 2013, 133(12):2968-2979.
98. Gholami A., Salarilak S., Hejazi S., Khalkhali H.R. Birth weight and risk of childhood acute leukaemia. East Mediterr Health J 2013, 19:156-161.
99. Roman E., Lightfoot T., Smith A.G., Forman M.R., Linet M.S., Robison L., et al. Childhood acute lymphoblastic leukaemia and birthweight: insights from a pooled analysis of case-control data from Germany, the United Kingdom and the United States. Eur J Cancer 2013, 49:1437-1447.
100. Samuelsen S.O., Bakketeig L.S., Tretli S., Johannesen T.B., Magnus P. Birth weight and childhood cancer. Epidemiology 2009, 20:484-487.
101. Caughey R.W., Michels K.B. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer 2009, 124:2658-2670.
102. Carozza S.E., Langlois P.H., Miller E.A., Canfield M. Are children with birth defects at higher risk of childhood cancers. Am J Epidemiol 2012, 175:1217-1224.
103. Rankin J., Silf K.A., Pearce M.S., Parker L., Ward Platt M. Congenital anomaly and childhood cancer: a population-based, record linkage study. Pediatr Blood Cancer 2008, 51:608-612.
104. Agha M.M., Williams J.I., Marrett L., To T., Zipursky A., Dodds L. Congenital abnormalities and childhood cancer. Cancer 2005, 103:1939-1948.
105. Infante-Rivard C., Amre D.K. Congenital anomalies in children with acute lymphoblastic leukaemia and in their family. Int J Epidemiol 2001, 30:350-352.
106. Altmann A.E., Halliday J.L., Giles G.G. Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer 1998, 78:1244-1249.
107. Mertens A.C., Wen W., Davies S.M., Steinbuch M., Buckley J.D., Potter J.D., et al. Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr 1998, 133:617-623.
108. Narod S.A., Hawkins M.M., Robertson C.M., Stiller C.A. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 1997, 60:474-485.
109. Zack M., Adami H.O., Ericson A. Maternal and perinatal risk factors for childhood leukemia. Cancer Res 1991, 51:3696-3701.
110. Kinlen L.J. An examination, with a meta-analysis, of studies of childhood leukaemia in relation to population mixing. Br J Cancer 2012, 107:1163-1168.
111. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006, 6:193-203.
112. Einav U., Tabach Y., Getz G., Yitzhaky A., Ozbek U., Amariglio N., et al. Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer. Oncogene 2005, 24:6367-6375.
113. Ford A.M., Palmi C., Bueno C., Hong D., Cardus P., Knight D., et al. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. J Clin Investig 2009, 119:826-836.
114. Franciotta D., Verri A., Zardini E., Andreoni L., De Amici M., Moratti R., et al. Interferon-gamma- and interleukin-4-producing T cells in Down's syndrome. Neurosci Lett 2006, 395:67-70.
115. Maroun L.E. Interferon action and chromosome 21 trisomy (Down syndrome): 15 years later. J Theor Biol 1996, 181:41-46.
116. Murphy M., Insoft R.M., Pike-Nobile L., Epstein L.B. A hypothesis to explain the immune defects in Down syndrome. Progress Clin Biol Res 1995, 393:147-167.
117. Jourdan-Da Silva N., Perel Y., Mechinaud F., Plouvier E., Gandemer V., Lutz P., et al. Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer 2004, 90:139-145.
118. Chan L.C., Lam T.H., Li C.K., Lau Y.L., Li C.K., Yuen H.L., et al. Is the timing of exposure to infection a major determinant of acute lymphoblastic leukaemia in Hong Kong. Paediatric Perinat Epidemiol 2002, 16:154-165.
119. Perrillat F., Clavel J., Auclerc M.F., Baruchel A., Leverger G., Nelken B., et al. Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer 2002, 86:1064-1069.
120. Rudant J., Orsi L., Menegaux F., Petit A., Baruchel A., Bertrand Y., et al. Childhood acute leukemia, early common infections, and allergy: the ESCALE study. Am J Epidemiol 2010, 172:1015-1027.
121. Roman E., Simpson J., Ansell P., Kinsey S., Mitchell C., McKinney P., et al. Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol 2007, 165:496-504.
122. Crouch S., Lightfoot T., Simpson J., Smith A., Ansell P., Roman E. Infectious illness in children subsequently diagnosed with acute lymphoblastic leukemia: modeling the trends from birth to diagnosis. Am J Epidemiol 2012, 176:402-408.
123. Chang J.S., Tsai C.R., Tsai Y.W., Wiemels J.L. Medically diagnosed infections and risk of childhood leukaemia: a population-based case-control study. Int J Epidemiol 2012, 41:1050-1059.
124. Urayama K.Y., Ma X., Selvin S., Metayer C., Chokkalingam A.P., Wiemels J.L., et al. Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer 2011, 128:1632-1643.
125. Ma X., Buffler P.A., Wiemels J.L., Selvin S., Metayer C., Loh M., et al. Ethnic difference in daycare attendance, early infections, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2005, 14:1928-1934.
126. Cardwell C.R., McKinney P.A., Patterson C.C., Murray L.J. Infections in early life and childhood leukaemia risk: a UK case-control study of general practitioner records. Br J Cancer 2008, 99:1529-1533.
127. Vestergaard T.R., Rostgaard K., Grau K., Schmiegelow K., Hjalgrim H. Hospitalisation for infection prior to diagnosis of acute lymphoblastic leukaemia in children. Pediatr Blood Cancer 2013, 60:428-432.
128. MacArthur A.C., McBride M.L., Spinelli J.J., Tamaro S., Gallagher R.P., Theriault G.P. Risk of childhood leukemia associated with vaccination, infection, and medication use in childhood. Am J Epidemiol 2008, 167:598-606.
129. Urayama K.Y., Buffler P.A., Gallagher E.R., Ayoob J.M., Ma X. A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol 2010, 39:718-732.
130. Von Behren J., Spector L.G., Mueller B.A., Carozza S.E., Chow E.J., Fox E.E., et al. Birth order and risk of childhood cancer: a pooled analysis from five US States. Int J Cancer 2011, 128:2709-2716.
131. Hjalgrim L.L., Rostgaard K., Hjalgrim H., Westergaard T., Thomassen H., Forestier E., et al. Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. J Natl Cancer Inst 2004, 96:1549-1556.
132. Altieri A., Castro F., Bermejo J.L., Hemminki K. Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology. Cancer Epidemiol Biomarkers Prev 2006, 15:1281-1286.
133. Kwan M.L., Buffler P.A., Abrams B., Kiley V.A. Breastfeeding and the risk of childhood leukemia: a meta-analysis. Public Health Rep 2004, 119:521-535.
134. Martin R.M., Gunnell D., Owen C.G., Smith G.D. Breast-feeding and childhood cancer: a systematic review with metaanalysis. Int J Cancer 2005, 117:1020-1031.
135. Kwan M.L., Buffler P.A., Wiemels J.L., Metayer C., Selvin S., Ducore J.M., et al. Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2005, 93:379-384.
136. Linabery A.M., Jurek A.M., Duval S., Ross J.A. The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol 2010, 171:749-764.
137. Dahl S., Schmidt L.S., Vestergaard T., Schuz J., Schmiegelow K. Allergy and the risk of childhood leukemia: a meta-analysis. Leukemia 2009, 23:2300-2304.
138. Chang J.S., Tsai Y.W., Tsai C.R., Wiemels J.L. Allergy and risk of childhood acute lymphoblastic leukemia: a population-based and record-based study. Am J Epidemiol 2012, 176:970-978.
139. Tal N., Shochat C., Geron I., Bercovich D., Izraeli S. Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia. Cellular and molecular life sciences. CMLS 2014, 71:365-378.
140. Wakeford R. The risk of childhood leukaemia following exposure to ionising radiation - a review. J Radiol Prot 2013, 33:1-25.
141. Rajaraman P., Simpson J., Neta G., Berrington de Gonzalez A., Ansell P., Linet M.S., et al. Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: case-control study. BMJ 2011, 342:d472.
142. Bartley K., Metayer C., Selvin S., Ducore J., Buffler P. Diagnostic X-rays and risk of childhood leukaemia. Int J Epidemiol 2010, 39:1628-1637.
143. Pearce M.S., Salotti J.A., Little M.P., McHugh K., Lee C., Kim K.P., et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012, 380:499-505.
144. Kheifets L., Ahlbom A., Crespi C.M., Draper G., Hagihara J., Lowenthal R.M., et al. Pooled analysis of recent studies on magnetic fields and childhood leukaemia. Br J Cancer 2010, 103:1128-1135.
145. Ahlbom A., Day N., Feychting M., Roman E., Skinner J., Dockerty J., et al. A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer 2000, 83:692-698.
146. Greenland S., Sheppard A.R., Kaune W.T., Poole C., Kelsh M.A. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Epidemiology 2000, 11:624-634.
147. Milne E., Royle J.A., Miller M., Bower C., de Klerk N.H., Bailey H.D., et al. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer 2010, 126:2690-2699.
148. Latino-Martel P., Chan D.S., Druesne-Pecollo N., Barrandon E., Hercberg S., Norat T. Maternal alcohol consumption during pregnancy and risk of childhood leukemia: systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010, 19:1238-1260.
149. Bonaventure A., Rudant J., Goujon-Bellec S., Orsi L., Leverger G., Baruchel A., et al. Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms. Cancer Causes Control 2013, 24:783-793.
150. Castro-Jimenez M.A., Orozco-Vargas L.C. Parental exposure to carcinogens and risk for childhood acute lymphoblastic leukemia, Colombia, 2000-2005. Prev Chronic Dis 2011, 8:A106.
151. Infante-Rivard C., Krajinovic M., Labuda D., Sinnett D. Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes. Epidemiology 2002, 13:277-281.
152. Shu X.O., Ross J.A., Pendergrass T.W., Reaman G.H., Lampkin B., Robison L.L. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Children's Cancer Group study. J Natl Cancer Inst 1996, 88:24-31.
153. Milne E., Greenop K.R., Scott R.J., de Klerk N.H., Bower C., Ashton L.J., et al. Parental alcohol consumption and risk of childhood acute lymphoblastic leukemia and brain tumors. Cancer Causes Control 2013, 24:391-402.
154. MacArthur A.C., McBride M.L., Spinelli J.J., Tamaro S., Gallagher R.P., Theriault G. Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study. Cancer Causes Control 2008, 19:283-295.
155. Milne E., Greenop K.R., Scott R.J., Bailey H.D., Attia J., Dalla-Pozza L., et al. Parental prenatal smoking and risk of childhood acute lymphoblastic leukemia. Am J Epidemiol 2012, 175:43-53.
156. Lee K.M., Ward M.H., Han S., Ahn H.S., Kang H.J., Choi H.S., et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res 2009, 33:250-258.
157. Liu R., Zhang L., McHale C.M., Hammond S.K. Paternal smoking and risk of childhood acute lymphoblastic leukemia: systematic review and meta-analysis. J Oncol 2011, 2011:854584.
158. Menegaux F., Ripert M., Hemon D., Clavel J. Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia: a French population-based case-control study. Paediatric Perinat Epidemiol 2007, 21:293-299.
159. Brondum J., Shu X.O., Steinbuch M., Severson R.K., Potter J.D., Robison L.L. Parental cigarette smoking and the risk of acute leukemia in children. Cancer 1999, 85:1380-1388.
160. Chang J.S., Selvin S., Metayer C., Crouse V., Golembesky A., Buffler P.A. Parental smoking and the risk of childhood leukemia. Am J Epidemiol 2006, 163:1091-1100.
161. Rudant J., Menegaux F., Leverger G., Baruchel A., Lambilliotte A., Bertrand Y., et al. Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE). Cancer Causes Control 2008, 19:1277-1290.
162. Sorahan T., Prior P., Lancashire R.J., Faux S.P., Hulten M.A., Peck I.M., et al. Childhood cancer and parental use of tobacco: deaths from 1971 to 1976. Br J Cancer 1997, 76:1525-1531.
163. Sorahan T., Lancashire R.J., Hulten M.A., Peck I., Stewart A.M. Childhood cancer and parental use of tobacco: deaths from 1953 to 1955. Br J Cancer 1997, 75:134-138.
164. Cocco P., Rapallo M., Targhetta R., Biddau P.F., Fadda D. Analysis of risk factors in a cluster of childhood acute lymphoblastic leukemia. Arch Environ Health 1996, 51:242-244.
165. Bailey H.D., Armstrong B.K., de Klerk N.H., Fritschi L., Attia J., Scott R.J., et al. Exposure to professional pest control treatments and the risk of childhood acute lymphoblastic leukemia. Int J Cancer 2011, 129:1678-1688.
166. Van Maele-Fabry G., Lantin A.-C., Hoet P., Lison D. Residential exposure to pesticides and childhood leukaemia: a systematic review and meta-analysis. Environ Int 2011, 37:280-291.
167. Turner M.C., Wigle D.T., Krewski D. Residential pesticides and childhood leukemia a systematic review and meta-analysis. Environ Health Perspect 2009, 118.
168. Wigle D.T., Turner M.C., Krewski D. A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure. Environ Health Perspect 2009, 117:1505-1513.
169. Reid A., Glass D.C., Bailey H.D., Milne E., Armstrong B.K., Alvaro F., et al. Parental occupational exposure to exhausts, solvents, glues and paints, and risk of childhood leukemia. Cancer Causes Control 2011, 22:1575-1585.
170. Bailey H.D., Milne E., de Klerk N.H., Fritschi L., Attia J., Cole C., et al. Exposure to house painting and the use of floor treatments and the risk of childhood acute lymphoblastic leukemia. Int J Cancer 2011, 128:2405-2414.
171. Scelo G., Metayer C., Zhang L., Wiemels J.L., Aldrich M.C., Selvin S., et al. Household exposure to paint and petroleum solvents, chromosomal translocations, and the risk of childhood leukemia. Environ Health Perspect 2009, 117:133-139.
172. Freedman D.M., Stewart P., Kleinerman R.A., Wacholder S., Hatch E.E., Tarone R.E., et al. Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health 2001, 91:564-567.
173. Schuz J., Kaletsch U., Meinert R., Kaatsch P., Michaelis J. Risk of childhood leukemia and parental self-reported occupational exposure to chemicals, dusts, and fumes: results from pooled analyses of German population-based case-control studies. Cancer Epidemiol Biomarkers Prev 2000, 9:835-838.
174. Shu X.O., Stewart P., Wen W.Q., Han D., Potter J.D., Buckley J.D., et al. Parental occupational exposure to hydrocarbons and risk of acute lymphocytic leukemia in offspring. Cancer Epidemiol Biomarkers Prev 1999, 8:783-791.
175. van Steensel-Moll H.A., Valkenburg H.A., van Zanen G.E. Childhood leukemia and parental occupation. A register-based case-control study. Am J Epidemiol 1985, 121:216-224.
176. Brown R.C., Dwyer T., Kasten C., Krotoski D., Li Z., Linet M.S., et al. Cohort profile: the international childhood cancer cohort consortium (I4C). Int J Epidemiol 2007, 36:724-730.
177. Centers for Disease Control and Prevention National Center for Health Statistics 2010, National Vital Statistics System Birth Data.